Head Of Myanmar Drug, Device Group Seeks Bad-Imports Clampdown
This article was originally published in PharmAsia News
Executive SummaryThe head of Myanmar's drug and medical-device organization called for a government crackdown on illegal imports of fake and substandard competing products. The Myanmar Pharmaceutical and Medical Equipment Entrepreneurs Association. said importers should consider the public health when they trade in pharmaceuticals. Myanmar relies on imports for 80 percent of pharmaceuticals consumed in the country, most produced in Bangladesh, China, Indonesia, Malaysia, South Korea, Thailand and some European nations. Domestically produced drugs are made by only three factories of a single company, Myanmar Pharmaceutical Industry. (Click here for more
You may also be interested in...
ConMed’s ambitions in orthopedics are to be the clinician’s support, develop differentiated offerings and avoid “me too” activity, before all notions of leading the market rankings.
Executives On The Move: Tech And Science Announcements At Orexo And Agios, And Board Changes At Accorda And RhoVac
Swedish pharma Orexo welcomes EVP, digital health and anti-cancer therapeutics firm Agios Pharmaceuticals announces Bristol-Myers Squibb exec as its next CSO. And a chair takes a seat at Accorda Therapeutics and RhoVac.
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.